| Financial Year |
March 31 2023 |
| Monetary Funds |
456,678,207.62 |
| Held-for-trading Financial Assets |
390,385,766.53 |
| Notes Receivable |
11,618,000.00 |
| Accounts Receivable |
336,728,863.07 |
| Advances to Suppliers |
33,089,503.58 |
| Other Receivables |
19,524,010.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
485,541,119.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
591,120.26 |
| Total Current Assets |
1,839,532,386.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
133,111,009.36 |
| Investment Properties |
-- |
| Fixed Assetes |
236,461,854.12 |
| Under-construction Projects |
4,314,454.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
217,508,618.75 |
| R&D expenses |
157,320,829.07 |
| Goodwill |
2,986,578.98 |
| Long-Term Deferred and Prepaid Expenses |
103,487,618.19 |
| Deferred Income Tax Assets |
101,726,391.19 |
| Other Non-Current Assets |
12,086,481.78 |
| Sub-Total of Non-Current Assets |
1,396,678,950.30 |
| Total Assets |
3,236,211,337.25 |
| Short-Term Loans |
21,618,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
62,896,596.67 |
| Accounts Payable |
110,328,841.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,987,670.04 |
| Taxes Payable |
13,927,408.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,129,565.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,743,813.21 |
| Other Current Liabilities |
3,104,291.39 |
| Sub-Total of Current Liabilities |
370,175,336.45 |
| Long-term Loans |
1,696,874.42 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,075,714.27 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,705,417.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
383,173,376.86 |
| Total Liabilities |
753,348,713.31 |
| Paid-In Capital(Or Share Stock) |
501,417,333.00 |
| Capital Surplus |
1,357,060,457.98 |
| Surplus Reserve |
86,193,083.66 |
| LESS:Treasury Stock |
131,178,739.27 |
| Undistributed Profits |
584,848,288.82 |
| Minority Stockholder's Interest |
89,753,111.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,393,109,512.36 |
| Owner's Equity（Stockholder's Equity） |
2,482,862,623.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,236,211,337.25 |
